SARS-CoV-2 / COVID-19

Since the end of 2019, a novel virus that can cause respiratory diseases and pneumonia has been spreading worldwide. The pathogen SARS-CoV-2 belongs to the coronavirus family and is closely related to the SARS virus, which caused a pandemic in 2002. Here we will keep you informed about current developments in research and provide answers to the most important questions.

Researchers at the HZI are highly demanded interview partners on the topic of coronavirus SARS-CoV-2 and provide assessments of the situation. Here you can find selected articles (further articles are available in German):

Fighting COVID with SORMAS

SORMAS software was originally developed for managing the Ebola epidemic in Nigeria. The Nigerian newspaper The Guardian reports how this gave the country a unique advantage when the pandemic hit. [read more]

What happens to COVID during flu season?

Autumn and winter are commonly the season for colds and influenza. In an interview with DW, Gérard Krause assessed what happens when these infections meet COVID-19. [read more]

Combating COVID-19 in Germany: Key takeaways

Immunologist Michael Meyer-Hermann explains in an interview with the International Journalists' Network (IJN) how Germany is acting against COVID-19 and what can be expected in the next months. [read more]

Will coronavirus immunity passports work?

Some countries are considering issuing 'immunity passports' for those who have recovered from the coronavirus. Al Jazeera spoke about the pros and cons of this measure with HZI researcher Gérard Krause, among others. [read more]

Coronavirus

The coronaviruses are a family of viruses that includes a series of very different pathogens. These viruses usually infect mammals, rodents, and birds, but only few coronaviruses adapted to humans. They did this with great success: About one third of all typical "common colds" and some cases of diarrhoea as well are caused by these RNA Viruses, which are the largest of their kind. [more]

Support

With your donation to the HZI you directly support innovative coronavirus research projects that contribute to solutions for the containment of the virus and the identification of possible therapies. [more]

Involved research groups

PrintSend per emailShare